Discussion about this post

User's avatar
James Emanuel's avatar

In a conversation with Dayton Judd, I dropped the question about whether M&A scope may be broadened to encompass opportunities in other sectors.

The response was both emphatic and encouraging, "Our focus is definitely on the supplement space for right now. There are a lot of opportunities, and we have the platform and expertise to absorb them without learning a new industry or dramatically expanding our team."

This suggests that acquisitive growth is certain to continue and that FitLife will continue to grow. This company ought to be seen as a consolidation machine within a niche industry.

Expand full comment
Philip Grayson's avatar

Share price has dropped to $10.40 (after 2 for 1 split).

Some impact from tariffs on import of ingredients from China, albeit CEO says they made some anticipatory stock purchases ahead of tariff announcement.

Buying opportunity?

Expand full comment
1 more comment...

No posts